CPDC Appoints John Valliant as Chair of the Board

Hamilton, Ontario – October 19 – CPDC (Centre for Probe Development and Commercialization) today announced the appointment of Dr. John Valliant as Chair of its Board of Directors. Dr. Valliant succeeds Damian Lamb, who will continue to serve as a Director on the Board. In 2008, while a professor at McMaster University, Dr. Valliant founded … Read more

CPDC Announces the Appointment of Dr. Lana Janes as Chief Scientific Officer

HAMILTON, ON – October 16, 2026 – CPDC (Centre for Probe Development and Commercialization) is pleased to announce the appointment of Dr. Lana Janes as Chief Scientific Officer of the company, effective October 16, 2026. Dr. Janes has served on CPDC’s Board of Directors since 2021, providing strategic leadership during a period of significant changes … Read more

Call for Ideas: New Canadian Approaches in Radiopharmaceuticals 2026

CQDM and CPDC are pleased to announce the launch of the 2026 Call for Ideas: New Canadian Approaches in Radiopharmaceuticals, a national initiative designed to identify and support innovative Canadian technologies, discoveries, and companies that can contribute to the next generation of radiopharmaceuticals. Canada has developed internationally recognized expertise across the radiopharmaceutical value chain, from … Read more

CPDC Launches Cadena Research, a Radiopharmaceutical Preclinical CRO

Cadena Research empowers radiopharmaceutical innovators by delivering tailored solutions that accelerate the path to clinical translation. Hamilton, Ontario – September 29, 2025 – CPDC, a global leader in the development and commercialization of radiopharmaceuticals, is proud to announce the launch of Cadena Research, a new preclinical contract research organization (CRO) offering specialized support for early-stage drug … Read more

CPDC Announces Seed Investment in Radiosyn Ltd.

HAMILTON, ON, June 12, 2025 – CPDC, a global leader in the development and commercialization of radiopharmaceuticals, today announced a $650,000 seed investment in RadioSyn Ltd., a Hamilton-based startup company developing a miniaturized automated radiopharmaceutical synthesis device. The shielded synthesizer uses disposable microfluidic chips to perform end-to-end chemical and radiochemical reactions to synthesize radiopharmaceuticals at … Read more

Lab2Market Partners with CPDC to Launch L2M Discover Radiopharma Program

HAMILTON, ON, June 12, 2025 – CPDC and Lab2Market (L2M) today announced the L2M Discover Radiopharma program, a groundbreaking initiative to cultivate entrepreneurial skills among Canadian researchers in the radiopharmaceutical sector. Beginning on September 16, 2025, the 10-week virtual training program will equip students and faculty with the foundational tools necessary to embark on their … Read more

Call for Ideas: New Canadian Approaches in Radiopharmaceuticals

CQDM and the Centre for Probe Development and Commercialization (CPDC) are pleased to announce a strategic initiative  to support the development of next-generation radiopharmaceuticals in Canada. This collaboration represents a unique opportunity to align Canada’s strengths and global expertise in this expanding field. Together we are initiating a collective effort that will foster innovation and growth, and we … Read more

1st Annual CMIE-CNIC Symposium on Medical Isotopes a Resounding Success in Vancouver – CMIE

Vancouver, B.C. – December 17, 2024 – The inaugural Symposium on Medical Isotopes, hosted by the Canadian Medical Isotope Ecosystem (CMIE) in partnership with the Canadian Nuclear Isotope Council (CNIC), took place on December 12-13, 2024, at the Holiday Inn & Suites in Vancouver. The event attracted over 70 key stakeholders from across Canada’s medical isotope … Read more

CPDC Marks Sixteen Years of Innovation and Success

Celebrating our Contribution to Advancing Nuclear Medicine for the World HAMILTON, ON, March 19, 2024 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development and commercialization of radiopharmaceuticals, is proud to celebrate its 16th anniversary today. Since 2008, CPDC has been at the forefront of advancing nuclear medicine for … Read more